A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb

被引：0
|
作者：
Joy, Stephen T. [1 ]
Henley, Matthew J. [1 ,2 ]
De Salle, Samantha N. [1 ,2 ]
Beyersdorf, Matthew S. [1 ,2 ]
Vock, Isaac W. [1 ,3 ]
Huldin, Allison J. L. [1 ,4 ]
Mapp, Anna K. [1 ,2 ,4 ]
机构：
[1] Joy, Stephen T.
[2] 1,Henley, Matthew J.
[3] 1,De Salle, Samantha N.
[4] 1,Beyersdorf, Matthew S.
[5] 1,Vock, Isaac W.
[6] 1,Huldin, Allison J. L.
[7] 1,2,Mapp, Anna K.
来源：
Mapp, Anna K. (amapp@umich.edu) | 1600年 / American Chemical Society卷 / 143期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Journal article (JA)
引用
收藏
页码：15056 / 15062
相关论文
共 50 条
  • [21] Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
    Bowers, Erin M.
    Yan, Gai
    Mukherjee, Chandrani
    Orry, Andrew
    Wang, Ling
    Holbert, Marc A.
    Crump, Nicholas T.
    Hazzalin, Catherine A.
    Liszczak, Glen
    Yuan, Hua
    Larocca, Cecilia
    Saldanha, S. Adrian
    Abagyan, Ruben
    Sun, Yan
    Meyers, David J.
    Marmorstein, Ronen
    Mahadevan, Louis C.
    Alani, Rhoda M.
    Cole, Philip A.
    CHEMISTRY & BIOLOGY, 2010, 17 (05): : 471 - 482
  • [22] Combination Targeting of the Bromodomain and Acetyltransferase Active Site of p300/CBP
    Zucconi, Beth E.
    Makofske, Jessica L.
    Meyers, David J.
    Hwang, Yousang
    Wu, Mingxuan
    Kuroda, Mitzi I.
    Cole, Philip A.
    BIOCHEMISTRY, 2019, 58 (16) : 2133 - 2143
  • [23] NEO2734, a novel dual BET and P300/CBP bromodomain inhibitor, is more active in NUT midline carcinoma than single agent BET or P300/CBP inhibitors
    Tian, Tian
    Cosin, Marc
    Giles, Francis
    Brana, Irene
    Garralda, Elena
    Peiro, Sandra
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [24] Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
    Loren M. Lasko
    Clarissa G. Jakob
    Rohinton P. Edalji
    Wei Qiu
    Debra Montgomery
    Enrico L. Digiammarino
    T. Matt Hansen
    Roberto M. Risi
    Robin Frey
    Vlasios Manaves
    Bailin Shaw
    Mikkel Algire
    Paul Hessler
    Lloyd T. Lam
    Tamar Uziel
    Emily Faivre
    Debra Ferguson
    Fritz G. Buchanan
    Ruth L. Martin
    Maricel Torrent
    Gary G. Chiang
    Kannan Karukurichi
    J. William Langston
    Brian T. Weinert
    Chunaram Choudhary
    Peter de Vries
    Arthur F. Kluge
    Michael A. Patane
    John H. Van Drie
    Ce Wang
    David McElligott
    Edward A. Kesicki
    Ronen Marmorstein
    Chaohong Sun
    Philip A. Cole
    Saul H. Rosenberg
    Michael R. Michaelides
    Albert Lai
    Kenneth D. Bromberg
    Nature, 2018, 558 : E1 - E1
  • [25] HTLV-1 HBZ Protein Deregulates Interactions between Cellular Factors and the KIX Domain of p300/CBP
    Cook, Pamela R.
    Polakowski, Nicholas
    Lemasson, Isabelle
    JOURNAL OF MOLECULAR BIOLOGY, 2011, 409 (03) : 384 - 398
  • [26] Genetic Interaction between Mutations in c-Myb and the KIX Domains of CBP and p300 Affects Multiple Blood Cell Lineages and Influences Both Gene Activation and Repression
    Kasper, Lawryn H.
    Fukuyama, Tomofusa
    Lerach, Stephanie
    Chang, Yunchao
    Xu, Wu
    Wu, Song
    Boyd, Kelli L.
    Brindle, Paul K.
    PLOS ONE, 2013, 8 (12):
  • [27] Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules
    Facchinetti, V
    Loffarelli, L
    Schreek, S
    Oelgeschlager, M
    Luscher, B
    Introna, M
    Golay, J
    BIOCHEMICAL JOURNAL, 1997, 324 : 729 - 736
  • [28] Functional redundancy between the transcriptional activation domains of E2A is mediated by binding to the KIX domain of CBP/p300
    Denis, Christopher M.
    Langelaan, David N.
    Kirlin, Alyssa C.
    Chitayat, Seth
    Munro, Kim
    Spencer, Holly L.
    LeBrun, David P.
    Smith, Steven P.
    NUCLEIC ACIDS RESEARCH, 2014, 42 (11) : 7370 - 7382
  • [29] Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases
    Ji, Zhiqin
    Clark, Richard F.
    Bhat, Vikram
    Hansen, T. Matthew
    Lasko, Loren M.
    Bromberg, Kenneth D.
    Manaves, Vlasios
    Algire, Mikkel
    Martin, Ruth
    Qiu, Wei
    Torrent, Maricel
    Jakob, Clarissa G.
    Liu, Hong
    Cole, Philip A.
    Marmorstein, Ronen
    Kesicki, Edward A.
    Lai, Albert
    Michaelides, Michael R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 39
  • [30] Discovery of berberine analogs as potent and highly selective p300/CBP HAT inhibitors
    Zhong, Xue
    Deng, Huiwen
    Long, Min
    Yin, Honglu
    Zhong, Qiu
    Zheng, Shilong
    Gong, Tao
    He, Ling
    Wang, Guangdi
    Sun, Qiu
    BIOORGANIC CHEMISTRY, 2023, 138
12345